

( (S (PP-TMP In
	     (NP (NP an age)
		 (PP of
		     (NP specialization))))
     ,
     (NP-SBJ the federal judiciary)
     (VP is
         (NP-PRD (NP one)
		 (PP of
		     (NP (NP the last bastions)
			 (PP of
			     (NP the generalist))))))
     .))
( (S (NP-SBJ-1 A judge)
     (VP must
         (VP (VP jump
		 (PP-DIR-2 from
			   (NP murder))
		 (PP-DIR-3 to
			   (NP antitrust cases)))
	     ,
	     (VP (PP-DIR=2 from
			   (NP arson))
		 (PP-DIR=3 to
			   (NP securities fraud)))
	     ,
	     (PP without
		 (S-NOM (NP-SBJ *-1)
			(VP missing
			    (NP a beat))))))
     .))
( (S But
     (ADVP even)
     (PP-LOC on
	     (NP the federal bench))
     ,
     (S (NP-SBJ specialization)
        (VP is
            (VP creeping
                (ADVP-CLR in))))
     , 
     and
     (S (NP-SBJ it)
        (VP has
            (VP become
                (NP-PRD (NP a subject)
			(PP of
			    (NP sharp controversy)))
                (PP-LOC on
			(NP the newest federal appeals court)))))
     .))
( (S (NP-SBJ-1 (NP The Court)
               (PP of
                   (NP Appeals))
               (PP for
                   (NP the Federal Circuit)))
     (VP was
         (VP created
             (NP *-1)
	     (PP-TMP in
		     (NP 1982))
	     (S-CLR (NP-SBJ *-1)
		    (VP to
			(VP serve
			    ,
			    (PP among
				(NP other things))
			    ,
			    (PP-CLR as
				    (NP (NP the court)
					(PP of
					    (NP last resort))))
			    (PP for
				(NP most patent disputes)))))))
     .))
( (S (ADVP-TMP Previously)
     ,
     (NP-SBJ patent cases)
     (VP moved
         (PP-DIR through
		 (NP the court system))
         (PP-DIR to
		 (NP (NP one)
		     (PP of
			 (NP the 12 circuit appeals
			     courts)))))
     .))
( (S (ADVP-LOC There)
     ,
     (NP-SBJ (NP judges)
             (SBAR (WHNP-1 who)
                   (S (S (NP-SBJ *T*-1)
                         (VP saw
                             (NP few such cases)))
                      and
                      (S (NP-SBJ *T*-1)
                         (VP had
                             (NP (NP no experience)
                                 (PP-LOC in
					 (NP the field))))))))
     (VP grappled
         (PP-CLR with
		 (NP (NP some)
		     (PP of
			 (NP (NP the
				 (ADJP most technical and complex)
				 disputes)
			     (ADJP imaginable))))))
     .))
( (S (NP-SBJ-1 A new specialty court)
     (VP was
         (VP sought
             (NP *-1)
             (PP by
                 (NP-LGS (NP patent experts)
			 ,
			 (SBAR (WHNP-2 who)
			       (S (NP-SBJ *T*-2)
				  (VP believed
				      (SBAR that
					    (S (NP-SBJ the generalists)
					       (VP had
						   (VP botched
						       (NP (ADJP too many) 
							   important , multimillion-dollar
							   cases))))))))))))
     .))
( (S (NP-SBJ Some patent lawyers)
     (VP had
         (VP hoped
             (SBAR that
		   (S (NP-SBJ-1 such a specialty court)
		      (VP would
			  (VP be
			      (VP filled
				  (NP *-1)
				  (PP-CLR with
					  (NP (NP experts)
					      (PP-LOC in
						      (NP the field)))))))))))
     .))
( (S But
     (S (NP-SBJ the Reagan administration)
        (VP thought
            (ADVP-MNR otherwise)))
     , 
     and
     (SINV (ADVP-PRD-TPC-1 so)
           (VP may
	       (ADVP-PRD *T*-1))
           (NP-SBJ the Bush administration))
     .))
( (S (PP-TMP Since
	     (NP 1984))
     ,
     (NP-SBJ the president)
     (VP has
         (VP filled
             (NP (NP four vacancies)
                 (PP-LOC in
			 (NP the Federal Circuit court)))
             (PP-CLR with
		     (NP non-patent lawyers))))
     .))
( (S (ADVP-TMP Now)
     (NP-SBJ (NP (QP only three of the 12)  
		 judges)
             (PRN --
		  (NP (NP Pauline Newman)
		      ,
		      (NP (NP Chief Judge Howard T. Markey)
			  ,
			  (NP 68))
		      , 
		      and
		      (NP (NP Giles Rich)
			  ,
			  (NP 85)))
		  --))
     (VP have
         (NP patent-law backgrounds))
     .))
( (S (NP-SBJ (NP The latter two)
             and
             (NP (NP Judge Daniel M. Friedman)
                 ,
                 (NP 73)
                 ,))
     (VP are
         (VP approaching
             (NP (NP senior status)
		 or 
		 (NP retirement))))
     .))
( (S (S (NP-SBJ Three seats)
        (ADVP-TMP currently)
        (VP are
            (ADJP-PRD vacant)))
     and
     (S (NP-SBJ-3 three others)
        (VP are
            (ADJP-PRD likely
		      (S (NP-SBJ-1 *-3)
			 (VP to
			     (VP be
				 (VP filled
				     (NP *-1)
				     (PP-TMP within
					     (NP a few years)))))))))
     , 
     so
     (S (NP-SBJ (NP patent lawyers)
                and
                (NP research-based industries))
        (VP are
            (VP making
                (NP (NP a new push)
                    (PP for
                        (NP (NP specialists)
                            (SBAR (WHNP-4 0)
				  (S (NP-SBJ-2 *T*-4)
				     (VP to
					 (VP be
					     (VP added
						 (NP *-2)
						 (PP-CLR to
							 (NP the court)))))))))))))
     .))
( (S (NP-SBJ (NP Several organizations)
             ,
             (PP including
                 (NP (NP the Industrial Biotechnical Association)
                     and
                     (NP the Pharmaceutical Manufacturers Association)))
             ,)
     (VP have
         (VP asked
             (NP-1 (NP the White House)
		   and
		   (NP Justice Department))
             (S (NP-SBJ *-1)
                (VP to
                    (VP name
                        (NP (NP candidates)
                            (PP with
                                (NP (UCP both
					 patent 
					 and 
					 scientific)
				    backgrounds))))))))
     .))
( (S (NP-SBJ The associations)
     (VP would
         (VP like
	     (S (NP-SBJ the court)
		(VP to
                    (VP include
			(NP (NP (QP between three and six)
				judges)
			    (PP with
				(NP specialized training))))))))
     .))
( (S (NP-SBJ (NP Some)
             (PP of
                 (NP the associations)))
     (VP have
         (VP recommended
             (NP (NP (NP Dr. Alan D. Lourie)
		     ,
		     (NP 54)
		     ,)
		 (NP (NP a former patent agent)
		     (PP with
			 (NP (NP a doctorate)
			     (PP in
				 (NP organic chemistry)))))
                 (SBAR (WHNP-1 who)
                       (S (NP-SBJ *T*-1)
			  (ADVP-TMP now)
                          (VP is
                              (NP-PRD (NP associate general counsel)
				      (PP with
					  (NP (NP SmithKline Beckman Corp.)
					      (PP-LOC in
						      (NP Philadelphia)))))))))))
     .))
( (S (NP-SBJ Dr. Lourie)
     (VP says
         (SBAR 0
               (S (NP-SBJ the Justice Department)
                  (VP interviewed
                      (NP him)
                      (NP-TMP last July)))))
     .))
( (S (NP-SBJ Their effort)
     (VP has
         (VP received
             (NP a lukewarm response)
             (PP-CLR from
		     (NP the Justice Department))))
     .))
( (SINV ``
        (S-TPC-4 (NP-SBJ We)
		 (VP do not
		     (VP feel
			 (SBAR that
			       (S (NP-SBJ-1 seats)
				  (VP are
				      (VP reserved
					  (NP *-1)
					  (PRN -LRB-
					       (PP-CLR for
						       (NP patent lawyers))
					       -RRB-))))))))
        , 
	''
        (VP says
	    (S *T*-4))
        (NP-SBJ (NP Justice spokesman
                    David Runkel)
                ,
                (SBAR (WHNP-3 who)
                      (S (NP-SBJ-5 *T*-3)
                         (VP declines
                             (S (NP-SBJ *-5)
                                (VP to
                                    (VP say
                                        (SBAR (WHADVP-6 how soon)
					      (S (NP-SBJ-2 a candidate)
						 (VP will
						     (VP be
							 (VP named
							     (NP *-2)
							     (ADVP-TMP *T*-6)))))))))))))
        .))
( (S `` 
     But
     (NP-SBJ we)
     (VP will
	 (VP take
	     (NP it)
	     (PP-CLR into
		     (NP consideration))))
     . 
     ''))
( (S (NP-SBJ-1 (NP The Justice Department 's)
               view)
     (VP is
         (VP shared
             (NP *-1)
             (PP by
                 (NP-LGS (NP other lawyers)
			 and
			 (NP (NP (NP (QP at least one)
				     member)
				 (PP of
				     (NP the court)))
			     ,
			     (NP Judge H. Robert Mayer)
			     ,
			     (NP (NP a former civil litigator)
				 (SBAR (WHNP-3 who)
				       (S (NP-SBJ *T*-3)
					  (VP served
					      (PP-LOC at
						      (NP the claims court trial level))
					      (SBAR-TMP before
							(S (NP-SBJ-2 he)
							   (VP was
							       (VP appointed
								   (NP *-2)
								   (PP-CLR to
									   (NP the Federal Circuit))
								   (ADVP-TMP (NP two years)
									     ago))))))))))))))
     .))
( (S-6 ``
       (NP-SBJ-2 I)
       (VP believe
	   (SBAR that
		 (S (NP-SBJ-4 any good lawyer)
		    (VP should
			(VP be
			    (ADJP-PRD able
				      (S (NP-SBJ *-4)
					 (VP to
					     (VP (VP figure
						     (PRT out)
						     (NP *RNR*-5))
						 and
						 (VP understand
						     (NP *RNR*-5))
						 (NP-5 patent law)))))))))
	   (PRN , 
		''
		(S (NP-SBJ Judge Mayer)
		   (VP says
		       (S *T*-6)))
		,)
	   (S-ADV (NP-SBJ *-2)
		  (VP adding
		      (SBAR that
			    ``
			    (S (NP-SBJ (NP it)
				       (S *EXP*-3))
			       (VP 's
				   (NP-PRD (NP the responsibility)
					   (PP of
					       (NP (NP (ADJP highly paid)
						       lawyers)
						   (PRN -LRB-
							(SBAR (WHNP-1 who)
							      (S (NP-SBJ *T*-1)
								 (VP argue
								     (PP-LOC before
									     (NP the court)))))
							-RRB-))))
				   (S-3 (NP-SBJ *)
					(VP to
					    (VP make
						(S (NP-SBJ us)
						   (VP understand 
						       -LRB-
						       (NP complex patent litigation) -RRB-)))))))))))
       .
       ''))
( (S Yet
     (NP-SBJ some lawyers)
     (VP point
         (PP-CLR to
		 (NP (NP (NP Eli Lilly & Co.)
			 vs.
			 (NP Medtronic , Inc.))
		     ,
		     (NP (NP the patent infringement case)
			 (SBAR (WHNP-2 0)
			       (S (NP-SBJ-3 the Supreme Court)
				  (NP-TMP this month)
				  (VP agreed
				      (S (NP-SBJ *-3)
					 (VP to
					     (VP review
						 (NP *T*-2))))))))
		     ,))
	 (PP-CLR as
		 (NP (NP an example)
		     (PP of
			 (NP (NP poor legal reasoning)
			     (PP by
				 (NP (NP judges)
				     (SBAR (WHNP-1 who)
					   (S (NP-SBJ *T*-1)
					      (VP lack
						  (NP patent litigation experience)))))))))))
     .))
( (S -LRB-
     (NP-SBJ Judge Mayer)
     (VP was not
	 (PP-LOC-PRD on
		     (NP the three-member panel)))
     . 
     -RRB-))
( (S (PP-LOC In
	     (NP the Lilly case))
     ,
     (NP-SBJ the appeals court)
     (VP (ADVP-MNR broadly)
	 construed
	 (S (NP-SBJ a federal statute)
	    (VP to
                (VP grant
                    (NP (NP Medtronic)
                        ,
                        (NP a medical device manufacturer)
                        ,)
                    (NP (NP an exemption)
                        (SBAR (WHADVP-1 0)
			      (S (NP-SBJ *)
				 (VP to
				     (VP infringe
					 (NP a patent)
					 (PP-LOC under
						 (NP certain circumstances))
					 (ADVP-MNR *T*-1))))))))))
     .))
( (S (SBAR-ADV If
	       (S (NP-SBJ the Supreme Court)
		  (VP holds
		      (PP-CLR in
			      (NP (NP Medtronic 's)
				  favor)))))
     ,
     (NP-SBJ the decision)
     (VP will
         (VP have
             (NP billion-dollar consequences)
	     (PP for
		 (NP (NP the manufacturers)
		     (PP of
			 (NP (NP medical devices)
			     ,
			     (NP color and food additives)
			     and
			     (NP (NP all other non-drug products)
				 (SBAR (WHNP-1 that)
				       (S (NP-SBJ *T*-1)
					  (VP required
					      (NP Food & Drug Administration approval)))))))))))
     .))
( (S (NP-SBJ (NP Lisa Raines)
             ,
             (NP (NP (NP a lawyer)
		     and
		     (NP (NP director)
			 (PP of
			     (NP government relations))))
		 (PP for
		     (NP the Industrial Biotechnical Association)))
             ,)
     (VP contends
         (SBAR that
               (S (NP-SBJ (NP a judge)
                          (ADJP well-versed
                                (PP in
                                    (NP (NP patent law)
                                        and
                                        (NP (NP the concerns)
                                            (PP of
                                                (NP research-based industries)))))))
                  (VP would
		      (VP have
			  (VP ruled
			      (ADVP-MNR otherwise)))))))
     .))
( (S And
     (NP-SBJ (NP Judge Newman)
             ,
             (NP a former patent lawyer)
             ,)
     (VP wrote
         (PP-LOC in
		 (NP her dissent))
	 (SBAR-TMP (WHADVP-1 when)
		   (S (NP-SBJ the court)
		      (VP denied
			  (NP (NP a motion)
			      (PP for
				  (NP (NP a rehearing)
				      (PP of
					  (NP the case))
				      (PP by
					  (NP the full court)))))
			  (ADVP-TMP *T*-1))))
	 ,
	 ``
	 (S (NP-SBJ (NP The panel 's)
		    judicial legislation)
	    (VP has
		(VP affected
		    (NP an
			important high-technological
			industry)
		    ,
		    (PP without
			(NP (NP regard)
			    (PP to
				(NP (NP the consequences)
				    (PP for
					(NP (NP research and innovation)
					    or
					    (NP the public interest)))))))))))
     . 
     ''))
( (SINV (VP Says
	    (S *ICH*-1))
        (NP-SBJ Ms. Raines)
        ,
	``
	(S-1 -LRB-
	     (NP-SBJ The judgment)
	     -RRB-
	     (VP confirms
		 (NP our concern
		     (SBAR that
			   (S (NP-SBJ (NP the absence)
				      (PP of
					  (NP patent lawyers))
				      (PP-LOC on
					      (NP the court)))
			      (VP could
				  (VP prove
				      (ADJP-PRD troublesome))))))))
	.))
